Evidence map›Paper›PMID 39163536›Full record

ArticleThe Pediatric infectious disease journal2024

Sulfamethoxazole-Trimethoprim Prophylaxis in Pediatric Oncology Patients With Glucose-6-Phosphate Dehydrogenase Deficiency.

Rachael M Stone, Cyrine E Haidar, Nancy M Kornegay, Patricia J Barker, Seth E Karol, Joshua Wolf, Jane S Hankins, Mary V Relling, Kristine R Crews

Abstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rachael M StoneFrom the Department of Pharmacy and Pharmaceutical Sciences.ORCID 0000-0001-7751-4948
Cyrine E HaidarFrom the Department of Pharmacy and Pharmaceutical Sciences.
Nancy M KornegayFrom the Department of Pharmacy and Pharmaceutical Sciences.
Patricia J BarkerFrom the Department of Pharmacy and Pharmaceutical Sciences.
Seth E KarolDepartment of Oncology.
Joshua WolfDepartment of Infectious Diseases.
Jane S HankinsDepartment of Global Pediatric Medicine and Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Mary V RellingFrom the Department of Pharmacy and Pharmaceutical Sciences.
Kristine R CrewsFrom the Department of Pharmacy and Pharmaceutical Sciences.ORCID 0000-0002-7558-558

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

We sought to determine whether Pneumocystis jirovecii pneumonia prophylaxis with sulfamethoxazole-trimethoprim (SMX-TMP) is associated with an increased frequency of acute hemolytic anemia in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency versus non-G6PD-deficient controls in a pediatric oncology population. There was no statistically significant difference in change in hemoglobin or transfusion requirements after starting SMX-TMP between groups. These findings suggest no increased risk of acute hemolytic anemia with SMX-TMP administered at prophylaxis doses in patients with G6PD deficiency.

Identifiers

PMID39163536
PMCPMC11802889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.